Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: A randomised, double-blind, placebo-controlled, phase 2a study
Christopher E. Brightling, Eugene R. Bleecker, Reynold A. Panettieri, Mona Bafadhel, Dewei She, Christine K. Ward, Xiao Xu, Claire Birrell, René van der Merwe
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: A randomised, double-blind, placebo-controlled, phase 2a study'. Together they form a unique fingerprint.